Cvs Pharmacy 10127 Durable Medical Equipment & Medical Supplies Location: 1634 Us Route 302, Barre, Vermont 05641 Phone: (802) 476-2550 |
Hannaford Food & Drug #129 Durable Medical Equipment & Medical Supplies Location: 456 S Barre Rd, Barre, Vermont 05641 Phone: (802) 479-0432 |
Walgreens #17518 Durable Medical Equipment & Medical Supplies Location: 355 N Main St, Barre, Vermont 05641 Phone: (802) 476-4311 |
Kinney Drugs # 11 Pharmacy Location: 800 Us Route 302 Berlin, Barre, Vermont 05641 Phone: (802) 476-6659 |
Barre Optical Company Medicare Supplier Location: 341 N Main St, Barre, Vermont 05641 Phone: (802) 476-7932 |
News Archive
A sea of pink t-shirts will stretch from Athens to Bologna to Frankfurt to Zurich to Antwerp today in an effort to raise public awareness about breast cancer. In five cities across Europe, breast cancer survivors, their families, friends, supporters and advocates will join forces in a show of strength, courage and solidarity.
Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer.
Breathing. Anyone reading this article is doing it right now. But what chemicals are we breathing in, and out? A group of Virginia Tech College of Engineering researchers has published a paper in the journal Environmental Science & Technology that details how to learn just that, using microelectromechanical systems to focus on toxins and everyday impurities that enter the body through the air we intake.
Cannabis Science Inc., a pioneering US biotech company developing pharmaceutical cannabis products, reports that Cannabis Science sent an email to Mr. Rick Rosio on July 23, 2010 notifying him that he appeared to be in serious breach of the non-disclosure/non-circumvention agreement that he and Montana Pain Management, Inc., had signed with Cannabis Science.
APEIRON Biologics AG announced that it has entered into an exclusive option to license from the Cleveland Clinic a number of novel compounds. These compounds are currently in development at Cleveland Clinic as drug candidates for treatment of various cancers, designed to fight cancer based on stimulation of the immune system. In preclinical models, they have shown anti-cancer activity and a favourable toxicity profile as orally available agents.
› Verified 7 days ago